These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

94 related articles for article (PubMed ID: 18443016)

  • 1. Effective dose: a flawed concept that could and should be replaced.
    Brenner DJ
    Br J Radiol; 2008 Jul; 81(967):521-3. PubMed ID: 18443016
    [TBL] [Abstract][Full Text] [Related]  

  • 2. We can do better than effective dose for estimating or comparing low-dose radiation risks.
    Brenner DJ
    Ann ICRP; 2012; 41(3-4):124-8. PubMed ID: 23089011
    [TBL] [Abstract][Full Text] [Related]  

  • 3. Radiation doses and risks from internal emitters.
    Harrison J; Day P
    J Radiol Prot; 2008 Jun; 28(2):137-59. PubMed ID: 18495991
    [TBL] [Abstract][Full Text] [Related]  

  • 4. Appropriate Use of Effective Dose in Radiation Protection and Risk Assessment.
    Fisher DR; Fahey FH
    Health Phys; 2017 Aug; 113(2):102-109. PubMed ID: 28658055
    [TBL] [Abstract][Full Text] [Related]  

  • 5. Effective dose: a radiation protection quantity.
    Menzel HG; Harrison J
    Ann ICRP; 2012; 41(3-4):117-23. PubMed ID: 23089010
    [TBL] [Abstract][Full Text] [Related]  

  • 6. The ICRP protection quantities, equivalent and effective dose: their basis and application.
    Harrison JD; Streffer C
    Radiat Prot Dosimetry; 2007; 127(1-4):12-8. PubMed ID: 18003712
    [TBL] [Abstract][Full Text] [Related]  

  • 7. Dose quantities in radiation protection and their limitations.
    Dietze G; Menzel HG
    Radiat Prot Dosimetry; 2004; 112(4):457-63. PubMed ID: 15623879
    [TBL] [Abstract][Full Text] [Related]  

  • 8. [Current aspects in the evaluation of radiation risk: from the risk to organs to total injury risk (effective equivalent doses)].
    Fritz-Niggli H
    Schweiz Med Wochenschr; 1985 Jan; 115(1):18-24. PubMed ID: 3969538
    [TBL] [Abstract][Full Text] [Related]  

  • 9. Effective dose: a flawed concept that could and should be replaced. Comments on a paper by D J Brenner (Br J Radiol 2008;81:521-3).
    Dietze G; Harrison JD; Menzel HG
    Br J Radiol; 2009 Apr; 82(976):348-50; author reply 350-1. PubMed ID: 19325049
    [No Abstract]   [Full Text] [Related]  

  • 10. Carcinogenesis and radiation risk: a biomathematical reconnaissance.
    Mayneord WV; Clarke RH
    Br J Radiol; 1975; Suppl 12():1-112. PubMed ID: 1234033
    [TBL] [Abstract][Full Text] [Related]  

  • 11. Dose-effect relationships, epidemiological analysis and the derivation of low dose risk.
    Leenhouts HP; Chadwick KH
    J Radiol Prot; 2011 Mar; 31(1):95-105. PubMed ID: 21346287
    [TBL] [Abstract][Full Text] [Related]  

  • 12. Modelling carcinogenesis after radiotherapy using Poisson statistics: implications for IMRT, protons and ions.
    Jones B
    J Radiol Prot; 2009 Jun; 29(2A):A143-57. PubMed ID: 19454805
    [TBL] [Abstract][Full Text] [Related]  

  • 13. Biokinetic and dosimetric modelling in the estimation of radiation risks from internal emitters.
    Harrison J
    J Radiol Prot; 2009 Jun; 29(2A):A81-A105. PubMed ID: 19454809
    [TBL] [Abstract][Full Text] [Related]  

  • 14. Cancer risk modelling and radiological protection.
    Wakeford R
    J Radiol Prot; 2012 Mar; 32(1):N89-93. PubMed ID: 22395099
    [TBL] [Abstract][Full Text] [Related]  

  • 15. Sensitivity analysis of parameters and methodological choices used in calculation of radiation detriment for solid cancer.
    Zhang W; Laurier D; Cléro E; Hamada N; Preston D; Vaillant L; Ban N
    Int J Radiat Biol; 2020 May; 96(5):596-605. PubMed ID: 31914349
    [No Abstract]   [Full Text] [Related]  

  • 16. A framework for estimating radiation-related cancer risks in Japan from the 2011 Fukushima nuclear accident.
    Walsh L; Zhang W; Shore RE; Auvinen A; Laurier D; Wakeford R; Jacob P; Gent N; Anspaugh LR; Schüz J; Kesminiene A; van Deventer E; Tritscher A; del Rosarion Pérez M
    Radiat Res; 2014 Nov; 182(5):556-72. PubMed ID: 25251702
    [TBL] [Abstract][Full Text] [Related]  

  • 17. Does electron and proton therapy reduce the risk of radiation induced cancer after spinal irradiation for childhood medulloblastoma? A comparative treatment planning study.
    Mu X; Björk-Eriksson T; Nill S; Oelfke U; Johansson KA; Gagliardi G; Johansson L; Karlsson M; Zackrisson DB
    Acta Oncol; 2005; 44(6):554-62. PubMed ID: 16165914
    [TBL] [Abstract][Full Text] [Related]  

  • 18. Alpha particles at energies of 10 MeV to 1 TeV: conversion coefficients for fluence-to-absorbed dose, effective dose, and gray equivalent, calculated using Monte Carlo radiation transport code MCNPX 2.7.A.
    Copeland K; Parker DE; Friedberg W
    Radiat Prot Dosimetry; 2010 Mar; 138(4):310-9. PubMed ID: 19933695
    [TBL] [Abstract][Full Text] [Related]  

  • 19. Cancer and non-cancer risks in normal and cancer-prone Trp53 heterozygous mice exposed to high-dose radiation.
    Carlisle SM; Burchart PA; Mitchel RE
    Radiat Res; 2010 Jan; 173(1):40-8. PubMed ID: 20041758
    [TBL] [Abstract][Full Text] [Related]  

  • 20. Doses and lung cancer risks from exposure to radon and plutonium.
    Marsh JW; Harrison JD; Laurier D; Birchall A; Blanchardon E; Paquet F; Tirmarche M
    Int J Radiat Biol; 2014 Nov; 90(11):1080-7. PubMed ID: 25066877
    [TBL] [Abstract][Full Text] [Related]  

    [Next]    [New Search]
    of 5.